Skip to content Skip to footer
Menu Close
Close

Oncology

Participate in a Colon Cancer Screening Study Focused on Advancing Earlier Detection of Colorectal Cancer and Precancerous Growths

FIND-CRC research study

Colorectal Cancer Clinical Trials

Colorectal cancer is one of the most common and preventable cancers, yet it remains the second leading cause of cancer-related deaths in the United States, largely because it is caught too late. Most people at average risk have no symptoms in the early stages, making routine screening one of the most powerful tools available.

Zillan Clinical Research is conducting the FIND-CRC colon cancer screening study for adults aged 40 years and older who are at average risk of developing colorectal cancer (CRC). Eligible participants may contribute to research evaluating an investigational screening test for colorectal cancer. Collected samples and study data will be analyzed to evaluate the clinical performance of the investigational screening test and help researchers better understand its potential role in future colorectal cancer screening.

Check Eligibility
About This Study

The FIND-CRC Research Study: Advancing How We Screen for Colorectal Cancer

When colorectal cancer goes undetected, it’s often not because screening doesn’t work, it’s because too many people never get screened at all. Access, preparation, and hesitation create a gap that costs lives.

The FIND-CRC research study is a prospective colon cancer screening study evaluating the performance of a blood-based investigational process in people at average risk of developing colorectal cancer. Participants provide a blood sample and undergo a standard-of-care colonoscopy within 120 days of their blood draw, free of any cost. Zillan Clinical Research is conducting this study with an effort to make colorectal cancer screening more accessible and less invasive for patients everywhere.

Now Enrolling

Current Status

Evaluation of an investigational screening test in an average risk population

Goal

Observational

Study Type

Enroll Now
Our Values

Why Patients Trust Us

At Zillan Clinical Research, we conduct ethical, high-quality clinical studies focused on patient safety, scientific integrity, and advancing innovative treatments for better health outcomes.

Integrity

Conducting all studies with honesty, transparency, and strict ethical standards

Patient Safety

Prioritizing participant well-being through close monitoring and care

Scientific Excellence

Following high-quality research practices and global clinical standards

Innovation

Supporting advanced research approaches that drive medical progress

Diversity & Inclusion

Ensuring studies reflect real-world patient populations

Trusted Oversight

Operating under regulated, GCP-compliant clinical research processes.

FAQ

Frequently Asked Questions

This study is a prospective colon cancer screening study evaluating a blood-based investigational process designed to detect colorectal cancer in people at average risk. Participants provide a blood sample and undergo a standard colonoscopy, with data analyzed to assess the test's clinical accuracy.

Adults aged 40 and older who are at average risk of colorectal cancer and are already planning or scheduled for a routine screening colonoscopy. Individuals with a prior cancer history, inflammatory bowel disease, or hereditary high-risk conditions are not eligible.

Participation involves providing a blood sample and having a standard-of-care colonoscopy completed within 120 days of that draw. Study visits are structured to align with your existing care plan, minimizing additional burden on your schedule.

No. As part of the study protocol, results from the blood test for colorectal cancer screening will not be shared with participants or their clinicians. The data is used solely for research purposes to evaluate the test's performance.

Participants provide a blood sample, complete scheduled study procedures, and undergo a standard screening colonoscopy within 120 days as part of the research process.

Yes. The study procedures, a blood draw and a standard colonoscopy, are routine medical processes. All participation follows strict ICH and GCP-compliant guidelines, with your safety and comfort as the top priority throughout.

Still have questions? Our team is here to support you.

Still have questions? Our team is here to support you with your clinical research needs.
Contact Our Team

Join Us

Supporting Innovation
Through Structured Clinical Trials

Join studies designed to advance medical knowledge and support the development of next-generation therapies.
Take the First Step Today